Tibet Aim Pharm Inc (002826)

Currency in CNY
17.60
-0.19(-1.07%)
Delayed Data·
Advertisement
002826 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
17.4617.85
52 wk Range
14.6526.83
Key Statistics
Bid/Ask
17.60 / 17.61
Prev. Close
17.79
Open
17.58
Day's Range
17.46-17.85
52 wk Range
14.65-26.83
Volume
4.18M
Average Volume (3m)
5.53M
1-Year Change
-22.7532%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
002826 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

Earnings

Latest Release
27/04/2026
EPS / Forecast
0.11 / --
Revenue / Forecast
182.58M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.51%
Dividend Yield
0.84%
Industry Median 1.75%
Annualised payout
0.15
Paid annually
5-Years Growth
+13.40%
Growth Streak

Compare 002826 to Peers and Sector

Metrics to compare
002826
Peers
Sector
Relationship
P/E Ratio
36.2x29.1x−0.4x
PEG Ratio
0.230.510.00
Price/Book
4.0x2.4x2.6x
Price / LTM Sales
5.0x4.2x3.1x
Upside (Analyst Target)
-24.0%48.2%
Fair Value Upside
Unlock12.1%5.8%Unlock

Tibet AIM Pharm. Inc. engages in the research and development, manufacturing, and sale of medical products in China. The company’s products include Miglitol tablets for diabetes; ethnic medicine products, suitable for treating breast lobular hyperplasia, uterine fibroids, and ovarian cysts; medicines for gynecology and obstetrics; and Gualoupi injection, Nalmefene hydrochloride injection, and Carbetocin injection. It also provides Domperidone tablets for treatment of indigestion, abdominal bloating, belching, nausea, vomiting, and abdominal distension and pain; Montmorillonite powder for chronic diarrhea; and Hongjin Xiaojie tablets and Aceclofenac Enteric-Coated tablets, as well as for the treatment of antibiotics, antiallergic, and digestive systems. Tibet AIM Pharm. Inc. was founded in 2003 and is based in Lhasa, China.

Employees
405
Market
China

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
3.41M1.79%60.81M
Other Institutional Investors
6.24M3.28%111.29M
Public Companies & Retail Investors
180.43M94.92%3.22B
Total
190.07M100.00%3.39B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Broad Asset Management Co., Ltd1.26%2,392,10042,675
CITIC Securities Asset Management (HK) Limited0.87%1,654,25529,512

FAQ

What Is the Tibet Aim Pharm (Shenzhen: 002826) Share Price Today?

The Tibet Aim Pharm stock price today is 17.60 CNY.

What Stock Exchange Does Tibet Aim Pharm (002826) Trade On?

Tibet Aim Pharm is listed and trades on the Shenzhen Stock Exchange.

What Is the Ticker (Stock Symbol) for Tibet Aim Pharm?

The stock symbol (also called a 'ticker') for Tibet Aim Pharm is "002826."

Does Tibet Aim Pharm Pay Dividends? What’s The Current 002826 Dividend Yield?

Yes, 002826 Pays Dividends to its Shareholders. The current Tibet Aim Pharm dividend yield is 0.84%.

What Is the Current Tibet Aim Pharm Market Capitalisation?

As of today, Tibet Aim Pharm (Shenzhen: 002826) market cap is 3.35B CNY.

What Is Tibet Aim Pharm's (002826) Earnings Per Share (TTM)?

The Tibet Aim Pharm EPS is currently 0.51 (Trailing Twelve Months).

Is 002826 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Tibet Aim Pharm moving averages and other technical indicators, the daily buy/sell signal for 002826 stock is Strong Buy.

How Many Times Has Tibet Aim Pharm Stock Split?

Tibet Aim Pharm has split 0 times. (See the 002826 stock split history page for full effective split date and price information.)

How Many Employees Does Tibet Aim Pharm Have?

Tibet Aim Pharm has 405 employees, based on their latest Companies House report.

What is the current trading status of Tibet Aim Pharm (Shenzhen: 002826)?

As of 11/08/2026, Tibet Aim Pharm (002826) is trading at a share price of 17.60 CNY, with a previous close of 17.79 CNY. The stock has fluctuated within a day range of 17.46 CNY to 17.85 CNY, while its 52-week range spans from 14.65 CNY to 26.83 CNY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.